These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36223271)

  • 21. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil for Crohn's disease?
    Lowry PW; Sandborn WJ; Lipsky JJ
    Lancet; 1999 Jul; 354(9172):3-4. PubMed ID: 10406354
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical therapies for ulcerative colitis and Crohn's disease.
    Baert FJ; Rutgeerts PJ
    Curr Gastroenterol Rep; 2000 Dec; 2(6):446-50. PubMed ID: 11079045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Crohn's disease--standards of treatment 2004].
    Kruis W
    Praxis (Bern 1994); 2005 Oct; 94(41):1595-8. PubMed ID: 16245637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil.
    Benez A; Fierlbeck G
    Br J Dermatol; 2001 Mar; 144(3):638-9. PubMed ID: 11260038
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of budesonide and mesalamine for active Crohn's disease.
    Lowry PW; Sandborn WJ
    Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil.
    Nousari HC; Goyal S; Anhalt GJ
    Arch Dermatol; 1999 Nov; 135(11):1420-1. PubMed ID: 10566854
    [No Abstract]   [Full Text] [Related]  

  • 28. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease.
    Loftus CG; Egan LJ; Sandborn WJ
    Gastroenterol Clin North Am; 2004 Jun; 33(2):141-69, vii. PubMed ID: 15177532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: maintenance treatment of Crohn's disease.
    Biancone L; Tosti C; Fina D; Fantini M; De Nigris F; Geremia A; Pallone F
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():31-7. PubMed ID: 12786610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolate mofetil therapy for refractory inflammatory bowel disease.
    Palaniappan S; Ford AC; Greer D; Everett SM; Chalmers DM; Axon AT; Hamlin PJ
    Inflamm Bowel Dis; 2007 Dec; 13(12):1488-92. PubMed ID: 17924566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug treatment of Crohn's disease].
    van Deventer SJ; Tytgat GN
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
    Glicklich D; Acharya A
    Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug safety in Crohn's disease therapy.
    Juillerat P; Pittet V; Felley C; Mottet C; Froehlich F; Vader JP; Gonvers JJ; Michetti P
    Digestion; 2007; 76(2):161-8. PubMed ID: 18239408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of mycophenolate mofetil in inflammatory bowel disease.
    Tan T; Lawrance IC
    World J Gastroenterol; 2009 Apr; 15(13):1594-9. PubMed ID: 19340901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil.
    Tagawa Y; Saito T; Takada K; Kawahata K; Kohsaka H
    Lupus; 2016 Apr; 25(5):543-6. PubMed ID: 26762472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.